Processa Pharmaceuticals, Inc. Common (PCSA) is a publicly traded Healthcare sector company. As of October 9, 2026, PCSA trades at $1.43 with a market cap of $3.97M and a P/E ratio of -0.15. PCSA moved -0.74% today. Year to date, PCSA is -53.92%; over the trailing twelve months it is -88.72%. Its 52-week range spans $1.32 to $19.64. Rallies surfaces PCSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $1.43 |
| Market Cap | $3.97M |
| P/E Ratio | -0.15 |
| EPS | $-10.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.64 |
| 52-Week Low | $1.32 |
| Volume | 2.65M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.56M |
| Gross Margin | 0.00% |
PCSA analyst coverage data. Average price target: $0.00.